Xwell (XWEL) Divestments (2017)

Xwell (XWEL) posted Divestments of -$372000.0 for Q4 2017, down 12.73% sequentially from -$330000.0 in Q3 2017.

Xwell (XWEL) Divestments (2017) Analysis & Trends

Xwell has reported Divestments for 1 years, with the latest figure at -$372000.0 in Q4 2017.

Quarterly Divestments changed N/A year-over-year to -$372000.0 in Q4 2017, while the trailing twelve-month figure through Sep 2018 was -$372000.0 (changed N/A YoY) and the FY2017 annual result came in at -$1.1 million, changed N/A from the prior year.
Divestments slipped to -$372000.0 in Q4 2017 per XWEL's latest filing, from -$330000.0 in the prior quarter.
Over five years, Divestments peaked at -$125000.0 in Q1 2017 and troughed at -$372000.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Thermo Fisher Scientific	213.40 Bn	209.33 Bn	8.34 Bn	-
2	Danaher	139.94 Bn	135.59 Bn	3.61 Bn	-
3	Idexx Laboratories	46.03 Bn	45.83 Bn	779.09 Mn	-
4	Agilent Technologies	39.69 Bn	37.88 Bn	990.00 Mn	-
5	Iqvia Holdings	39.32 Bn	37.24 Bn	1.44 Bn	-
6	Natera	38.47 Bn	37.37 Bn	696.04 Mn	-
7	Illumina	29.98 Bn	28.82 Bn	770.00 Mn	-
8	Mettler Toledo International	28.57 Bn	28.52 Bn	650.22 Mn	-
9	Quest Diagnostics	26.21 Bn	25.58 Bn	1.03 Bn	-
10	Xwell	7.40 Mn	-9.41 Mn	2.35 Mn	-

Download Data